Custom crystal celebrating a commercial rights agreement between pharmaceutical firm Zogenix and Nippon Shinyaku. Zogenix focuses on rare disease therapies.
(9ALj481)Custom crystal celebrating a commercial rights agreement between pharmaceutical firm Zogenix and Nippon Shinyaku. Zogenix focuses on rare disease therapies.
(9ALj481)Custom Lucite commemorating the acquisition of Igenomix, a Spanish provider of genetic testing services for reproductive health patients.
(9LSS177)Custom Lucite celebrating the inauguration of Andrew Rehfeld as President of Hebrew Union College.
(9AKL666)Custom crystal commemorative, incorporating a periodic table theme, marking a licensing and commercialization agreement for a cancer drug developed by Rockville, Maryland-based biotech firm GlycoMimetics. The agreement applies to mainland China, Hong Kong, Taiwan, and Macau.
(20ALJ071)Custom crystal celebrating Series A for Copenhagen-based podcast provider Podimo.
(20LJW11)Custom crystal marking construction of Our Medical Home North Lakes, located in Queensland’s Moreton Bay region. The facility is part of a network of medical centres operated by Australia’s Cornerstone Health.
(20AJH028)Custom crystal celebrating the opening of solar power facility near Fort Calhoun, Nebraska.
(20AKL005)Custom crystal celebrating the submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA). The application, related to Impel NeuroPharma’s migraine treatment INP104, was supported by a Phase 3, open-label STOP-301 Trial.
(20ALJ356)